Skip to main content
SpringerLink
Log in

Palliative Operations for Unresectable Pancreatic Cancer

  • Chapter
Multimodality Management of Borderline Resectable Pancreatic Cancer

  • 883 Accesses

Abstract

Although resection can provide long-term survival approaching 20 %, only 20–30 % of newly diagnosed cases of pancreatic adenocarcinoma are amenable to surgical resection and over 50 % of patients have distant disease at presentation. Knowledge of the various palliative operative and non-operative procedures is therefore critical in the multidisciplinary treatment of this disease. Palliative care for pancreas cancer encompasses a large number of medical, procedural, and surgical interventions that have evolved over the years. There are several surgical interventions available; some prophylactic and others designed for symptomatic relief. It is important to understand their benefits, applicability, and outcomes when compared to less invasive procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Werner J, Combs SE, Springfiled C, et al. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013;10(6):323–33.

    Article  CAS  PubMed  Google Scholar 

  2. Ahrendt SA, Pitt HA. Surgical management of pancreatic cancer. Oncology. 2001;16(6):725–34.

    Google Scholar 

  3. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200–10.

    Article  CAS  PubMed  Google Scholar 

  4. Singh SM, Longmire WP, Reber HA. Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg. 1990;212(2):132–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. House MG, Lillemoe KD. Palliative therapy for pancreatic cancer. In: Cameron JL, editor. Current surgical therapy. 8th ed. St Louis, MO: Mosby Inc; 2004. p. 504–10.

    Google Scholar 

  6. Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer. 2004;40:549–58.

    Article  CAS  PubMed  Google Scholar 

  7. Boyd AD, Riba M. Depression and pancreatic cancer. J Natl Compr Canc Netw. 2007;5:113–6.

    PubMed  Google Scholar 

  8. Ottery F. Supportive nutritional management of the patient with pancreatic cancer. Oncology (Williston Park). 1996;10:26–32.

    CAS  Google Scholar 

  9. Cote GA, Sherman S. Endoscopic palliation of pancreatic cancer. Cancer J. 2012;18(6):584–90.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Moss AC, Morris E, Leyden J, et al. Malignant distal biliary obstruction; a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33(2):213–21.

    Article  PubMed  Google Scholar 

  11. Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trails comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;12(12):1119–24.

    Article  Google Scholar 

  12. Bornan PC, Harries-Jones EP, Tobias R, et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet. 1986;1(8472):69–71.

    Article  Google Scholar 

  13. Shepard HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988;75(12):1166–8.

    Article  Google Scholar 

  14. Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344(8938):1655–60.

    Article  CAS  PubMed  Google Scholar 

  15. Artifon EL, Sakai P, Cunha JE, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol. 2006;101(9):2031–7.

    Article  PubMed  Google Scholar 

  16. Qadan M, Clarke S, Morrow E. et al. Sump syndrome as a complication of choledochoduodenostomy. Dig Dis Sci. 2012;57(8):2011–5.

    Article  PubMed  Google Scholar 

  17. Urbach DR, Bell CM, Swanstrom LL, et al. Cohort study o surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg. 2003;237(1):86–93.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Toumi Z, Aljarabah M, Ammori BJ. Role of laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review. Surg Endosc. 2011;25(7):2105–16.

    Article  PubMed  Google Scholar 

  19. Rothlin MA, Schob O, Weber M. Laparoscopic gastro- and hepaticojejunostomy for palliation of pancreatic cancer: a case controlled study. Surg Endosc. 1999;13(11):1065–7069.

    Article  CAS  PubMed  Google Scholar 

  20. Conrad C, Lillemoe KD. Surgical palliation of pancreatic cancer. Cancer J. 2012;18(6):577–83.

    Article  PubMed  Google Scholar 

  21. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004;24(1):269–71.

    PubMed  Google Scholar 

  22. Khashab M, Alawad AS, Shin EJ, et al. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc. 2013;27:2068–75.

    Article  PubMed  Google Scholar 

  23. Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006;20(2):239–42.

    Article  CAS  PubMed  Google Scholar 

  24. Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71(3):490–9.

    Article  PubMed  Google Scholar 

  25. No JH, Kim AW, Lim CH, et al. Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with very good performance status: endoscopic stenting versus surgery. Gastrointest Endosc. 2013;78(1):55–62.

    Article  PubMed  Google Scholar 

  26. Laval G, Avieux C, Stefani L, et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Gernoble University Hospital Center. J Pain Symptom Mange. 2006;31(6):502–12.

    Article  Google Scholar 

  27. Brookbank MA, Gane PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;1(6):520–6.

    Article  Google Scholar 

  28. Sialis AM, Pearce LF, Lestina LS, et al. Percutaneous radiologic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction of terminally ill patients with advanced carcinomas. Surg Endosc. 1999;13(11):1103–5.

    Article  Google Scholar 

  29. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999;230(3):322–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg. 2003;238(6):894–902.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Nikfarjam M, Kimchi ET, Gusani NJ, et al. A reduction in delayed gastric emptying by classic pancreaticoduodenectomy with an antecolic gastrojejunal anastomosis and a retrogastric omental patch. J Gastrointest Surg. 2009;13:1674–82.

    Article  PubMed  Google Scholar 

  32. Hatel M, Wente MN, Hinz U, et al. Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg. 2005;140:1094–9.

    Article  Google Scholar 

  33. Kuraha H, Shinchi H, Maemura K, et al. Delayed gastric emptying after pancreaticoduodenectomy. J Surg Res. 2011;171:187–92.

    Article  Google Scholar 

  34. Gangavatiker R, Pal S, Javed A, et al. Effect of antecolic or retrocolic reconstruction of the gastro/duodenojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled trial. J Gastrointest Surg. 2011;15:843–52.

    Article  PubMed  Google Scholar 

  35. Imamura N, Chijiiwa K, Ohuchida J, et al. Prospective randomized clinical trial of a change in gastric emptying and nutritional status after a pylorus-preserving pancreaticoduodenectomy: comparison between an antecolic and a vertical antecolic duodenojejunostomy. HPB. 2014;16:384–94.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Eshuis WJ, van Eijck CH, Gerhards MF, et al. Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreaticoduodenectomy: a randomized controlled trial. Ann Surg. 2014;259(1):45–51.

    Article  PubMed  Google Scholar 

  37. Sahora K, Morales-Oyarvide V, Thayer SP, et al. The effect of antecolic versus retrocolic reconstruction on delayed gastric emptying after classic non-pylorus-preserving pancreaticoduodenectomy. Am J Surg. 2015;209(6):1028–35.

    Article  PubMed  Google Scholar 

  38. House MG, Choti MA. Palliative therapy for pancreatic/biliary cancer. Surg Oncol Clin N Am. 2004;13:491–503.

    Article  PubMed  Google Scholar 

  39. Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;3, CD007519.

    PubMed  Google Scholar 

  40. Fabbri C, Luigiano C, Lisoti A, et al. Endoscopic ultrasound-guided treatments: are we getting evidence based—a systemic review. World J Gastroenterol. 2014;20(26):8424–48.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg. 1993;217(5):447–57.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Allen P, Chou J, Janakos M. Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Ann Surg Oncol. 2011;18:636–41.

    Article  PubMed  Google Scholar 

  43. Martin R, Philips P, Ellis S, et al. Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation. BMC Cancer. 2014;14(1):540.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Martin R, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2013;20:S443–9.

    Article  PubMed  Google Scholar 

  45. Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996;223:718–28.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Gillen S, Schuster T, Friess H, et al. Palliative resections versus palliative bypass procedures in pancreatic cancer—a systemic review. Am J Surg. 2012;203(4):496–502.

    Article  PubMed  Google Scholar 

  47. Walter J, Nier A, Rose T, et al. Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head. Eur J Surg Oncol. 2011;37(9):798–804.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Hishaam Ismael M.D. & Brian Badgwell M.D., M.S.

Authors
  1. Hishaam Ismael M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Badgwell M.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hishaam Ismael M.D. .

Editor information

Editors and Affiliations

  1. Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas, USA

    Matthew H.G. Katz

  2. Division of Surgical Oncology, The University of Cincinnati Medical Center, Cincinnati, Ohio, USA

    Syed A. Ahmad

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ismael, H., Badgwell, B. (2016). Palliative Operations for Unresectable Pancreatic Cancer. In: Katz, M., Ahmad, S. (eds) Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22780-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22780-1_20

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22779-5

  • Online ISBN: 978-3-319-22780-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation